STELLAR-303: A phase 3 study of XL092 in combination with atezolizumab versus regorafenib in patients with previously treated metastatic colorectal cancer

被引：0

作者：

Hecht, J. Randolph

Tabernero, Josep

Raj Parikh, Aparna

Wang, Yijia

Wang, Zhong

Schwickart, Martin

Curran, Dominic

Saeed, Anwaar

机构：

[1] UCLA, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Santa Monica, CA USA

[2] Vall Hebron Univ Hosp, Barcelona, Spain

[3] Vall Hebron Inst Oncol VHIO, Barcelona, Spain

[4] Harvard Med Sch, Dept Med, Div Hematol & Oncol, Massachusetts Gen Hosp, Boston, MA USA

[5] Exelixis Inc, Alameda, CA USA

[6] Univ Pittsburgh Med Ctr UPMC, Dept Med, Div Hematol & Oncol, UPMC Hillman Canc Ctr, Pittsburgh, PA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS3630

引用

页数：1